The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Carmichael Clare since 2010.
The trader's CIK number is 1441632.
At the time of the last reporting, Carmichael Clare was the SR VP, Human Resources of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN).
Also see all insider trading activities at Alexion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | WPI | 0 | $0 | 1,318 | $55,779 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALXN | 0 | $0 | 5,916 | $758,801 | 0 | $0 |
| 2016 | ALXN | 0 | $0 | 6,030 | $833,867 | 0 | $0 |
| 2015 | ALXN | 0 | $0 | 4,721 | $826,314 | 0 | $0 |
| 2014 | ALXN | 0 | $0 | 12,559 | $2,370,725 | 10,000 | $570,200 |
| 2013 | ALXN | 0 | $0 | 1,237 | $133,045 | 0 | $0 |
| 2012 | ALXN | 0 | $0 | 0 | $0 | 3,000 | $0 |
1. Watson Pharmaceuticals Inc (WPI)
2. Alexion Pharmaceuticals, Inc. (ALXN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-08-16 | WPI | Sale | 1,318 | 42.32 | 55,779 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-02-27 | ALXN | Sale | 860 | 131.20 | 112,831 |
| 2017-02-28 | ALXN | Sale | 915 | 131.71 | 120,514 |
| 2017-03-01 | ALXN | Sale | 404 | 132.50 | 53,530 |
| 2017-02-09 | ALXN | Sale | 167 | 126.84 | 21,182 |
| 2017-02-06 | ALXN | Sale | 3,404 | 126.17 | 429,482 |
| 2017-02-07 | ALXN | Sale | 166 | 128.09 | 21,262 |
| 2016-08-30 | ALXN | Sale | 1,000 | 127.76 | 127,760 |
| 2016-08-08 | ALXN | Sale | 165 | 137.14 | 22,628 |
| 2016-02-08 | ALXN | Sale | 2,665 | 138.39 | 368,809 |
| 2016-02-04 | ALXN | Sale | 207 | 144.47 | 29,905 |
| 2016-02-05 | ALXN | Sale | 1,993 | 142.88 | 284,765 |
| 2015-09-01 | ALXN | Sale | 305 | 168.62 | 51,429 |
| 2015-08-07 | ALXN | Sale | 163 | 190.01 | 30,971 |
| 2015-08-04 | ALXN | Sale | 185 | 196.52 | 36,356 |
| 2015-03-02 | ALXN | Sale | 706 | 180.34 | 127,320 |
| 2015-02-10 | ALXN | Sale | 1,490 | 171.15 | 255,013 |
| 2015-02-09 | ALXN | Sale | 1,665 | 173.75 | 289,293 |
| 2015-02-04 | ALXN | Sale | 207 | 173.59 | 35,932 |
| 2014-12-04 | ALXN | Option Ex | 10,000 | 57.02 | 570,200 |
| 2014-12-04 | ALXN | Sale | 10,000 | 196.25 | 1,962,500 |
| 2014-09-02 | ALXN | Sale | 304 | 169.46 | 51,515 |
| 2014-08-04 | ALXN | Sale | 184 | 158.23 | 29,114 |
| 2014-03-03 | ALXN | Sale | 305 | 174.77 | 53,304 |
| 2014-02-07 | ALXN | Sale | 1,006 | 156.59 | 157,534 |
| 2014-02-04 | ALXN | Sale | 760 | 153.63 | 116,758 |
| 2013-08-30 | ALXN | Sale | 1,237 | 107.56 | 133,045 |
| 2012-02-03 | ALXN | Option Ex | 3,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carmichael Clare (SR VP, Human Resources of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.